Global Low Molecular Weight Heparin Market Status and Outlook 2018-2025

July 2018 | 162 pages | ID: G1553B42DFAEN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Aspen
• Sanofi-aventis
• Pfizer
• Opocrin
• CSBIO
• Dongying Tiandong Pharmaceutical
• Changzhou Qianhong Bio-pharma
• Techdow
• Yantai Dongcheng Pharmaceutical Group

Market by Type

• Enoxaparin
• Dalteparin
• Tinzaparin
• Fraxiparine

Market by Application

• Treatment of Venous Thromboembolism
• Complications of Pregnancy
• Cardioversion of Atrial Fibrillation/Flutter
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Low Molecular Weight Heparin Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Enoxaparin
  3.1.2 Dalteparin
  3.1.3 Tinzaparin
  3.1.4 Fraxiparine
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Treatment of Venous Thromboembolism
  4.1.2 Complications of Pregnancy
  4.1.3 Cardioversion of Atrial Fibrillation/Flutter
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Enoxaparin Production by Region
    6.1.1.2 Dalteparin Production by Region
    6.1.1.3 Tinzaparin Production by Region
    6.1.1.4 Fraxiparine Production by Region
  6.1.2 Production by Application
    6.1.2.1 Treatment of Venous Thromboembolism Production by Region
    6.1.2.2 Complications of Pregnancy Production by Region
    6.1.2.3 Cardioversion of Atrial Fibrillation/Flutter Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Enoxaparin Demand by Region
    6.2.1.2 Dalteparin Demand by Region
    6.2.1.3 Tinzaparin Demand by Region
    6.2.1.4 Fraxiparine Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Treatment of Venous Thromboembolism Demand by Region
    6.2.2.2 Complications of Pregnancy Demand by Region
    6.2.2.3 Cardioversion of Atrial Fibrillation/Flutter Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Aspen
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Sanofi-aventis
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Pfizer
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Opocrin
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 CSBIO
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Dongying Tiandong Pharmaceutical
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Changzhou Qianhong Bio-pharma
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Techdow
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Yantai Dongcheng Pharmaceutical Group
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Low Molecular Weight Heparin Industry Dynamics & Regulations List
Table Global Low Molecular Weight Heparin Sales Revenue, Cost and Margin, 2015-2018E
Table Global Low Molecular Weight Heparin Market Status by Type 2015-2018E, in USD Million
Table Global Low Molecular Weight Heparin Market Status by Application 2015-2018E, in USD Million
Table Global Low Molecular Weight Heparin Market Status by Application 2015-2018E, in Volume
Table Global Low Molecular Weight Heparin Market by Region 2015-2018E, in USD Million
Table Global Low Molecular Weight Heparin Market Share by Region in 2018, in USD Million
Table Global Low Molecular Weight Heparin Market by Region 2015-2018E, in Volume
Table Global Low Molecular Weight Heparin Market Share by Region in 2018, in Volume
Table Enoxaparin Production Value by Region 2015-2018E, in USD Million
Table Enoxaparin Production Volume by Region 2015-2018E, in Volume
Table Dalteparin Production Value by Region 2015-2018E, in USD Million
Table Dalteparin Production Volume by Region 2015-2018E, in Volume
Table Tinzaparin Production Value by Region 2015-2018E, in USD Million
Table Tinzaparin Production Volume by Region 2015-2018E, in Volume
Table Fraxiparine Production Value by Region 2015-2018E, in USD Million
Table Fraxiparine Production Volume by Region 2015-2018E, in Volume
Table Treatment of Venous Thromboembolism Production Value by Region 2015-2018E, in USD Million
Table Treatment of Venous Thromboembolism Production Volume by Region 2015-2018E, in Volume
Table Complications of Pregnancy Production Value by Region 2015-2018E, in USD Million
Table Complications of Pregnancy Production Volume by Region 2015-2018E, in Volume
Table Cardioversion of Atrial Fibrillation/Flutter Production Value by Region 2015-2018E, in USD Million
Table Cardioversion of Atrial Fibrillation/Flutter Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Enoxaparin Market Size by Region 2015-2018E, in USD Million
Table Enoxaparin Market Size by Region 2015-2018E, in Volume
Table Dalteparin Market Size by Region 2015-2018E, in USD Million
Table Dalteparin Market Size by Region 2015-2018E, in Volume
Table Tinzaparin Market Size by Region 2015-2018E, in USD Million
Table Tinzaparin Market Size by Region 2015-2018E, in Volume
Table Fraxiparine Market Size by Region 2015-2018E, in USD Million
Table Fraxiparine Market Size by Region 2015-2018E, in Volume
Table Treatment of Venous Thromboembolism Market Size by Region 2015-2018E, in USD Million
Table Treatment of Venous Thromboembolism Market Size by Region 2015-2018E, in Volume
Table Complications of Pregnancy Market Size by Region 2015-2018E, in USD Million
Table Complications of Pregnancy Market Size by Region 2015-2018E, in Volume
Table Cardioversion of Atrial Fibrillation/Flutter Market Size by Region 2015-2018E, in USD Million
Table Cardioversion of Atrial Fibrillation/Flutter Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalLow Molecular Weight Heparin Forecast by Type 2019F-2025F, in USD Million
Table Low Molecular Weight Heparin Forecast by Type 2019F-2025F, in Volume
Table Low Molecular Weight Heparin Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Low Molecular Weight Heparin Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Low Molecular Weight Heparin Market Forecast by Region 2019F-2025F, in USD Million
Table Low Molecular Weight Heparin Market Forecast by Region 2019F-2025F, in Volume
Table Aspen Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Aspen
Table Sanofi-aventis Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Sanofi-aventis
Table Pfizer Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Pfizer
Table Opocrin Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Opocrin
Table CSBIO Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of CSBIO
Table Dongying Tiandong Pharmaceutical Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Dongying Tiandong Pharmaceutical
Table Changzhou Qianhong Bio-pharma Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Changzhou Qianhong Bio-pharma
Table Techdow Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Techdow
Table Yantai Dongcheng Pharmaceutical Group Information
Table Low Molecular Weight Heparin Sales, Cost, Margin of Yantai Dongcheng Pharmaceutical Group
Table Global Low Molecular Weight Heparin Sales Revenue by Company 2015-2017, in USD Million
Table Global Low Molecular Weight Heparin Sales Volume by Company 2015-2017, in Volume
Table Global Low Molecular Weight Heparin Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Low Molecular Weight Heparin Picture
Figure Low Molecular Weight Heparin Industry Chain Diagram
Figure Global Low Molecular Weight Heparin Sales Revenue 2015-2018E, in USD Million
Figure Global Low Molecular Weight Heparin Sales Volume 2015-2018E, in Volume
Figure Global Low Molecular Weight Heparin Market Status by Type 2015-2018E, in Volume
Figure North America Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure North America Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure Europe Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure Europe Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure South America Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure South America Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure Middle East Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure Africa Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in USD Million
Figure Africa Low Molecular Weight Heparin Market Size and Growth 2015-2018E, in Volume
Figure Global Low Molecular Weight Heparin Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Low Molecular Weight Heparin Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Low Molecular Weight Heparin Sales Price Forecast 2019F-2025F
Figure Global Low Molecular Weight Heparin Gross Margin Forecast 2019F-2025F
Figure Global Low Molecular Weight Heparin Sales Revenue by Company in 2018, in USD Million
Figure Global Low Molecular Weight Heparin Price by Company in 2018
Figure Global Low Molecular Weight Heparin Gross Margin by Company in 2018